AstraZeneca and partner Daiichi Sankyo have their first phase 3 data for TROP2-targeting antibody-drug conjugate (ADC) datopotamab deruxtecan (Dato-DXd) – in lung cancer – in one of the most ...
The theory behind antibody drug conjugates (ADCs) is simple yet elegant: by combining the specificity of a monoclonal antibody with the cytotoxicity of a potent small molecule drug, ADCs can precisely ...
Julia Kagan is a financial/consumer journalist and former senior editor, personal finance, of Investopedia. Greg Vote / Getty Images Flood insurance is a specialized type of property insurance that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback